FindMyKOL

Nikki Levin, MD

Enriched profile

Professor, UMass Chan Medical School · UMass Chan Medical School

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Worcester, MA · Northeast · United StatesSpecialtyDermatologyFocusDermatology and Skin Diseases+4
Last active 2022FindMyKOL type: RegionalLatest publication2022Online presenceNone verifiedPaymentsNone reportedNIH fundingNone on fileWhy? →

Nikki Levin is Professor, UMass Chan Medical School at UMass Chan Medical School. OpenAlex indexes 56 publications with 1,120 citations (h-index 17).

Data verified 27 Oct 2026

Overview

Updated 28 Oct 2026

Nikki Levin, M.D., is Professor, UMass Chan Medical School. The public record shows 56 publications with 1,120 citations (h-index 17), centered on Dermatology and Skin Diseases, Acne and Rosacea Treatments and Effects, Medicine and Dermatology Studies History.

  • Most recent indexed publication: 2022 · The British journal of dermatology
  • Top research focus: Dermatology and Skin Diseases

Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Psoriasis / Psoriatic ArthritisAtopic Dermatitis / EczemaPsoriasis (Derm)

Research focus

OpenAlex concept fingerprint
Dermatology and Skin DiseasesAcne and Rosacea Treatments and EffectsMedicine and Dermatology Studies HistoryPsoriasis: Treatment and PathogenesisDermatological diseases and infestations

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
56publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

1,120citations

Total citations across indexed works.

17h-index

Hirsch index (OpenAlex). i10-index 21.

Clinical & industry

trials, payments and federal funding
0clinical trials

Investigator role on registered studies.

View trials ↓
0companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →

Industry payments

No payments involving this person were reported to CMS in program years 2021–2024. Why? →

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    27.7%
    Azole Antifungal22.5%
    Ketoconazole100%
    Part D≥54 patients
    Tetracycline-class Drug2.9%
    Doxycycline Hyclate100%
    Part D<11 patients

    + 1 more class in this area

  • Cancer & immunology

    22.2%
    Phosphodiesterase 4 Inhibitor7%
    Otezla100%
    Part D<11 patients
    Interleukin-12 Antagonist5.2%
    Stelara100%
    Part D<11 patients

    + 3 more classes in this area

  • Dermatology

    20.3%
    Corticosteroid13.9%
    Triamcinolone Acetonide84%Fluocinolone Acetonide16%
    Part D<11 patients
    Interleukin-4 Receptor alpha Antagonist4%
    Dupixent Pen100%
    Part D<11 patients

    + 1 more class in this area

All 6 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 28 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 28 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

APRIL C. DENG10Michael F. Christman7Yuying Zhang6Dirk M. Elston6Kaitlyn M. Yim5Ryan Chen5Jane Margaret Grant-Kels5Patrick J. O'Donnell5Pius M. Brzoska4Zendee Elaba3Elizabeth Tkachenko3Karen Wiss3Joe W. Gray3Rebecca J. Droms3Colleen K. Gabel3Stephanie H. Choi3Kristen C. Corey2James A. Solomon2Karen Makhoul2Maria Yadira Hurley2Kristine M. Cornejo2Jeffrey Mailhot2Julie V. Schaffer2Désirée Ratner2Michelle Hure2Anthony Patrick Fernandez2Robert Thomas Brodell2Murad Alam2Kaitlin Blankenship2Robert Paul Dellavalle2Gerald R. Fink2John L. Meisenheimer2Dan Nguyen2Karen K. Fu2Melissa Michelon2Mark J. Scharf1Michael E. A. Cunningham1Piur M. Bnorka1Julie A. Fenner1Fnu Nutan1

Similar KOLs

Other experts from the same institution or the same specialty.